Department of Microbiology, Center of Excellence on Translational Research in Inflammation and Immunology (CETRII), Chulalongkorn University, Bangkok, Thailand.
Faculty of Medicine, Department of Microbiology, Chulalongkorn University, Bangkok, Thailand.
PLoS One. 2024 Oct 18;19(10):e0311774. doi: 10.1371/journal.pone.0311774. eCollection 2024.
Despite the well-established effects of aging on brain function and gut dysbiosis (an imbalance in gut microbiota), the influence of aging on sepsis-associated encephalopathy (SAE) and the role of probiotics in this context remain less understood.
C57BL/6J mice (8-week-old) were subcutaneously administered with 8 weeks of D-galactose (D-gal) or phosphate buffer solution (PBS) for aging and non-aging models, respectively, with or without 8 weeks of oral Lacticaseibacillus rhamnosus GG (LGG). Additionally, the impact of the condition media from LGG (LCM) was tested in macrophages (RAW 264.7 cells), microglia (BV-2 cells), and hippocampal cells (HT-22 cells).
Fecal microbiome analysis demonstrated D-gal-induced dysbiosis (reduced Firmicutes and Desulfobacterota with increased Bacteroidota and Verrucomicrobiota), which LGG partially neutralized the dysbiosis. D-gal also worsens cecal ligation and puncture (CLP) sepsis severity when compared with PBS-CLP mice, as indicated by serum creatinine (Scr) and alanine transaminase (ALT), but not mortality, neurological characteristics (SHIRPA score), and serum cytokines (TNF-α and IL-6). Additionally, D-gal-induced aging was supported by fibrosis in the liver, kidney, and lung; however, CLP sepsis did not worsen fibrosis. Interestingly, LGG attenuated all parameters (mortality, Scr, ALT, SHIRPA, and cytokines) in non-aging sepsis (PBS-CLP) while improving all these parameters, except for mortality and serum IL-6, in aging sepsis (D-gal CLP). For the in vitro test using lipopolysaccharide (LPS) stimulation, LCM attenuated inflammation in some parameters on RAW264.7 cells but not BV-2 and HT-22 cells, implying a direct anti-inflammatory effect of LGG on macrophages, but not in cells from the brain.
D-gal induced fecal dysbiosis and worsened sepsis severity as determined by Scr and ALT, and LGG could alleviate most of the selected parameters of sepsis, including SAE. However, the impact of LGG on SAE was not a direct delivery of beneficial molecules from the gut to the brain but partly due to the attenuation of systemic inflammation through the modulation of macrophages.
尽管衰老对大脑功能和肠道菌群失调(肠道微生物群落失衡)的影响已得到充分证实,但衰老对脓毒症相关性脑病(SAE)的影响以及益生菌在这方面的作用仍知之甚少。
将 8 周龄的 C57BL/6J 小鼠分别皮下给予 8 周 D-半乳糖(D-gal)或磷酸盐缓冲液(PBS)以建立衰老和非衰老模型,并用或不用 8 周口服鼠李糖乳杆菌 GG(LGG)进行处理。此外,还在巨噬细胞(RAW 264.7 细胞)、小胶质细胞(BV-2 细胞)和海马细胞(HT-22 细胞)中测试了来自 LGG 的条件培养基(LCM)的影响。
粪便微生物组分析表明,D-gal 诱导的肠道菌群失调(厚壁菌门和脱硫弧菌减少,拟杆菌门和疣微菌门增加),而 LGG 部分中和了这种失调。与 PBS-CLP 小鼠相比,D-gal 还加重了盲肠结扎和穿刺(CLP)脓毒症的严重程度,血清肌酐(Scr)和丙氨酸转氨酶(ALT)升高,但死亡率、神经特征(SHIRPA 评分)和血清细胞因子(TNF-α和 IL-6)没有升高。此外,D-gal 诱导的衰老在肝脏、肾脏和肺部纤维化中得到证实;然而,CLP 脓毒症并未加重纤维化。有趣的是,LGG 减轻了非衰老性脓毒症(PBS-CLP)中的所有参数(死亡率、Scr、ALT、SHIRPA 和细胞因子),而在衰老性脓毒症(D-gal CLP)中除了死亡率和血清 IL-6 外,所有参数均得到改善。对于使用脂多糖(LPS)刺激的体外试验,LCM 在一些参数上减弱了 RAW264.7 细胞的炎症反应,但在 BV-2 和 HT-22 细胞中没有减弱,这意味着 LGG 对巨噬细胞有直接的抗炎作用,但对大脑细胞没有作用。
D-gal 诱导粪便菌群失调,并通过 Scr 和 ALT 加重脓毒症的严重程度,而 LGG 可以减轻脓毒症的大多数选定参数,包括 SAE。然而,LGG 对 SAE 的影响不是有益分子从肠道直接传递到大脑,而是部分通过调节巨噬细胞来减轻全身炎症。